Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease

Jan. 17, 2022

New 3,5-diaryl-substituted pyrazoles inhibit prostate cancer cell growth

Jan. 17, 2022

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Jan. 17, 2022

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

Machine learning approach speeds resistance identification

Jan. 17, 2022

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Jan. 17, 2022

Study brings clarity on how MS starts, although not yet why

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...